► The curfew at 6 p.m. not sufficient, the executive is considering several scenarios
Faced with the ineffectiveness of the 6 p.m. curfew, which does not “sufficiently slow down” the spread of Covid-19, government spokesman Gabriel Attal announced that the government was considering “Different scenarios” which will “From maintaining the current framework to very tight confinement”.
→ READ. Covid-19: “very tight confinement” is one of the scenarios considered
President Emmanuel Macron asked “Additional analyzes” before making a decision. Jean Castex will lead, Thursday and Friday, a series of consultations with parliamentarians, associations of elected officials and social partners.
► Sanofi will produce the Pfizer-BioNTech vaccines but continue its own research
Without being able to offer its own vaccine against Covid-19 for the moment, the French laboratory Sanofi will bottle that of its competitors Pfizer and BioNTech and package more than 100 million doses this year for the European Union.
Produce for a competitor “Is a first”, underlined Olivier Bogillot, the France boss of the laboratory, Wednesday January 27 on RTL, adding that “The stake is not at all economic but the capacity to distribute them as quickly as possible”.
→ EXPLANATION. Covid-19: how to speed up vaccine production?
The Sanofi vaccine, originally announced for the summer of 2021, suffered a setback after disappointing clinical trials. he “Will arrive by the end of the year.” We expect to have very good efficiency ”, said Olivier Bogillot.
► AstraZeneca in turmoil
The European Union is asking the AstraZeneca laboratory to deliver anti-Covid-19 vaccines produced in two factories located in the United Kingdom as agreed, European Health Commissioner Stella Kyriakides said on Wednesday. According to a European source, the group plans to deliver in the 1st quarter only” A quarter “ doses initially promised to the 27.
In the contract signed by the EU in August, for up to 400 million doses of the AstraZeneca / Oxford vaccine, the British laboratory had to use four factories to ensure its production: two in the EU including one in Belgium, and two in the UK, according to a European official. “UK factories are part of the pre-order contract and that’s why they have to deliver” the doses that are expected of them, she hammered.
Ahead of an EU regulatory green light for this vaccine expected on Friday, January 29, AstraZeneca announced last week that deliveries would be smaller than expected in the first quarter due to a “Drop in yield” at a European manufacturing site. The group was summoned twice on Monday to explain itself to member states and the European Commission, which is negotiating on behalf of the Twenty-Seven. His justifications were judged “Unsatisfactory” and another meeting was scheduled for Wednesday evening.
► The United Kingdom crosses the threshold of 100,000 dead, Boris Johnson apologizes
The United Kingdom became the first European country on Tuesday to cross the threshold of 100,000 deaths from Covid-19, the government deploying all its efforts in vaccination to get out of the health crisis aggravated by the variant that has appeared on its soil. Boris Johnson, accused of underestimating the extent of the crisis in the spring, confined too late and deconfined too strongly last summer, said he did “All he could” against the pandemic and apologized.
→ READ. British variant of Covid-19: a porous border between England and France
The British government announced on Wednesday that residents of the United Kingdom returning from 22 countries where variants of the virus “Present a risk”, such as South Africa, Portugal and countries in South America would be subject to a quarantine at the hotel.
► In the United States, the goal is to vaccinate the entire population by the end of the summer
The United States plans to order 200 million additional doses of Covid-19 vaccine with the goal of being able to vaccinate the entire American population by the end of the summer, the House announced Tuesday, January 26. -White.
→ ANALYSIS. United States: Joe Biden decrees maximum mobilization against Covid
With these purchases, half consisting of Pfizer’s vaccine and the other half of Moderna’s, “The United States will have enough doses to fully immunize 300 million Americans by the end of the summer”, be there “Totality” of the population, explained the presidency in a statement.